ClassID:

21647

A61K2300/00 - page 4 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#901
20190194663
2019-06-27

MicroRNA-198 as a tumor suppressor in ovarian cancer

#902
20190192541
2019-06-27

Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases

#903
20190192514
2019-06-27

Tank-binding kinase-1 PROTACs and associated methods of use

#904
20190192472
2019-06-27

Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease

#905
20190192451
2019-06-27

Sphingosine pathway modulating compounds for the treatment of cancers

#906
20190183933
2019-06-20

Biologically relevant orthogonal cytokine/receptor pairs

#907
20190183911
2019-06-20

Effervescent formulation based on pyridoxal-5-phosphate

#908
20190183892
2019-06-20

Combined pharmaceutical composition

#909
20190183837
2019-06-20

Compositions and methods of use of phorbolesters

#910
20190175575
2019-06-13

METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES

#911
20190175473
2019-06-13

Topical antimicrobial composition

#912
20190169248
2019-06-06

Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

#913
20190167633
2019-06-06

COMBINATION THERAPY FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

#914
20190167588
2019-06-06

BLENDED FORMULATIONS

#915
20190151401
2019-05-23

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

#916
20190151275
2019-05-23

Composition for treatment of neurodegenerative disease

#917
20190142938
2019-05-16

Triple combination therapy for treating Crohn's disease

#918
20190142849
2019-05-16

Pharmaceutical composition containing celecoxib

#919
20190142846
2019-05-16

Prevention of adverse effects caused by CD3 specific binding domains

#920
20190142783
2019-05-16

Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma

#921
20190142766
2019-05-16

USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME

#922
20190134085
2019-05-09

Insulin resistance and beta cell function using lysine-based supplements

#923
20190134044
2019-05-09

Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer

#924
20190133983
2019-05-09

Therapeutic Composition for Coincident Drinking Detoxification

#925
20190133641
2019-05-09

Recovery and processing of human embryos formed in vivo

#926
20190133135
2019-05-09

Altering microbial populations and modifying microbiota

#927
20190127449
2019-05-02

Compositions and methods for treating and preventing infections

#928
20190125845
2019-05-02

Compositions and methods for treatment of homocystinuria

#929
20190125816
2019-05-02

Herbo-mineral formulation for prevention, treatment and management of diabetes and method of preparation thereof

#930
20190119266
2019-04-25

Compositions and methods for inhibiting kinases

#931
20190117639
2019-04-25

COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE

#932
20190112299
2019-04-18

Crystalline form of lumacaftor

#933
20190111064
2019-04-18

STATIN + VITAMIN D COMBINATION DRUG AND METHOD OF USE

#934
20190111033
2019-04-18

USE OF GABOXADOL IN THE TREATMENT OF TINNITUS

#935
20190105404
2019-04-11

Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid

#936
20190105402
2019-04-11

ExPEC glycoconjugate vaccine formulations

#937
20190105364
2019-04-11

Method of using a gel, rinse, and spray for management of post-oral surgical recovery and maintenance of oral health

#938
20190105357
2019-04-11

Topical medicament for skin and mucosal injuries

#939
20190105356
2019-04-11

Systems and methods for thrombosis prevention

#940
20190105354
2019-04-11

Topical Skin Care Compositions and Methods

#941
20190105333
2019-04-11

Methods for inhibiting muscle atrophy

#942
20190105327
2019-04-11

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

#943
20190105315
2019-04-11

COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES

#944
20190105313
2019-04-11

Psilocybin compositions

#945
20190105294
2019-04-11

Amino acid compositions and methods for the treatment of liver diseases

#946
20190100754
2019-04-04

Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53

#947
20190100511
2019-04-04

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

#948
20190099492
2019-04-04

CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS

#949
20190099467
2019-04-04

Methods and compositions for preserving retinal ganglion cells

#950
20190099440
2019-04-04

Method for olfactory improvement with saccharide

#951
20190099434
2019-04-04

NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME

#952
20190099429
2019-04-04

CENICRIVIROC FOR THE TREATMENT OF FIBROSIS

#953
20190099422
2019-04-04

Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin

#954
20190099420
2019-04-04

Systems pharmacology for treating ocular disorders

#955
20190099419
2019-04-04

Procaspase combination therapy for glioblastoma

#956
20190099418
2019-04-04

Procaspase 3 activation by combination therapy

#957
20190099398
2019-04-04

Use of tetrahydrocannabinol and/or cannabidiol for increasing radiosensitivity in the treatment of a brain tumour

#958
20190099391
2019-04-04

Glucagon Antagonists

#959
20190099386
2019-04-04

COMPOSITIONS AND METHODS FOR TREATING OPIOID RECEPTOR ASSOCIATED DISEASES

#960
20190099335
2019-04-04

Buffered microencapsulated compositions and methods

#961
20190099334
2019-04-04

Buffered microencapsulated compositions and methods

#962
20190094227
2019-03-28

Disease-associated antigens and methods of use thereof

#963
20190093109
2019-03-28

Compositions and methods to promote bone formation and their uses including for the treatment of cancer

#964
20190092787
2019-03-28

Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections

#965
20190092781
2019-03-28

FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

#966
20190092755
2019-03-28

Compounds for treatment of cancer

#967
20190092754
2019-03-28

5-(N-BENZYL TETRAHYDROISOQUINOLIN-6-YL) PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#968
20190091333
2019-03-28

Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents

#969
20190091302
2019-03-28

Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency

#970
20190091289
2019-03-28

HSP for use in treatment for imiquimod related side effects

#971
20190091283
2019-03-28

Combination therapy for ischemia

#972
20190091272
2019-03-28

ANTI-CANCER DRUG COMPOSITION INCLUDING GANODERMA EXTRACT AND AMPHOTERICIN B

#973
20190091259
2019-03-28

Selective Chemotherapy Treatments and Diagnostic Methods Related Thereto

#974
20190091250
2019-03-28

Method of increasing relative abundance of oscillospira

#975
20190091243
2019-03-28

FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA

#976
20190091232
2019-03-28

METHOD OF TREATING MICROBIAL INFECTIONS

#977
20190091221
2019-03-28

Methods and compositions for treating viral or virally-induced conditions

#978
20190091217
2019-03-28

METHODS FOR INHIBITING TIE-2 KINASE USEFUL IN THE TREATMENT OF CANCER

#979
20190091209
2019-03-28

METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS

#980
20190091193
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#981
20190091192
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#982
20190091191
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

#983
20190091190
2019-03-28

COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS

#984
20190091188
2019-03-28

Therapy for transthyretin-associated amyloidosis

#985
20190091175
2019-03-28

METHOD OF REDUCTION MEDICATION IN TREATING DRAVET SYNDROME

#986
20190091174
2019-03-28

METHOD OF REDUCING SEIZURE TYPE EXPERIENCED BY A DRAVET PATIENT

#987
20190091173
2019-03-28

METHOD OF INCREASING TIME BETWEEN CONVULSIVE SEIZURES

#988
20190091156
2019-03-28

Milrinone controlled-release formulation

#989
20190091155
2019-03-28

COMBINATION TABLET WITH CHEWABLE OUTER LAYER

#990
20190085043
2019-03-21

FUSION PROTEINS FOR TREATING A METABOLIC SYNDROME

#991
20190085017
2019-03-21

6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY

#992
20190084984
2019-03-21

Calcium channel agonists

#993
20190084949
2019-03-21

NEW CLASS OF MU-OPIOID RECEPTOR AGONISTS

#994
20190084941
2019-03-21

Compounds and methods of treating infections

#995
20190083566
2019-03-21

ANTIOXIDANT DIETARY SUPPLEMENT AND RELATED METHOD

#996
20190083551
2019-03-21

PROBIOTIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF OBESITY AND OBESITY-RELATED CONDITIONS

#997
20190083528
2019-03-21

NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS

#998
20190083523
2019-03-21

Methods and compositions for the activation of gamma-delta T-cells

#999
20190083500
2019-03-21

Combination of PI3K Inhibitor and C-Met Inhibitor

#1000
20190083494
2019-03-21

Therapeutic Compositions

#1001
20190083483
2019-03-21

Bromodomain and extra-terminal protein inhibitor combination therapy

#1002
20190083479
2019-03-21

COMBINATION MEDICATION

#1003
20190083477
2019-03-21

Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures

#1004
20190083475
2019-03-21

Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor

#1005
20190083451
2019-03-21

Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors

#1006
20190083450
2019-03-21

Derivatives of korormicin useful as antibiotics

#1007
20190083445
2019-03-21

METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY

#1008
20190083431
2019-03-21

Methods and compositions to inhibit dependence on opioids

#1009
20190083430
2019-03-21

Methods and Compositions to Inhibit Symptoms Associated with Opioid Withdrawal

#1010
20190083424
2019-03-21

Formulation for inhibiting formation of 5-HTagonists and methods of using same

#1011
20190083421
2019-03-21

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

#1012
20190083411
2019-03-21

Pharmaceutical compositions of pimobendan

#1013
20190083410
2019-03-21

Pharmaceutical compositions of pimobendan

#1014
20190077852
2019-03-14

ANTI-EMP2 THERAPY REDUCES CANCER STEM CELLS

#1015
20190077801
2019-03-14

Inhibitors of KRAS G12C and methods of using the same

#1016
20190077800
2019-03-14

Derivatives and methods of treating hepatitis B infections

#1017
20190077783
2019-03-14

Mixtures of cannabinoid compounds, and production and use thereof

#1018
20190077755
2019-03-14

Small molecule androgen receptor inhibitors and methods of use thereof

#1019
20190077749
2019-03-14

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

#1020
20190076584
2019-03-14

SUBSTRATES FOR NITRIC OXIDE RELEASING DEVICES

#1021
20190076512
2019-03-14

Methods and kits for use in preventing and treating vulvovaginal candidiasis

#1022
20190076495
2019-03-14

Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine

#1023
20190076473
2019-03-14

AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS

#1024
20190076453
2019-03-14

Topical wash composition for use in acne patients

#1025
20190076449
2019-03-14

Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

#1026
20190076445
2019-03-14

Methods for Suppressing Allergic Reactions

#1027
20190076417
2019-03-14

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION

#1028
20190076409
2019-03-14

USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSY

#1029
20190076408
2019-03-14

Extended release methazolamide formulation

#1030
20190076389
2019-03-14

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

#1031
20190076388
2019-03-14

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

#1032
20190074086
2019-03-07

Ophthalmic drug delivery

#1033
20190071675
2019-03-07

INHIBITORS OF DEK PROTEIN AND RELATED METHODS

#1034
20190070320
2019-03-07

Organomedicinals for imaging and treatment of neurodegenerative disorders

#1035
20190070264
2019-03-07

Interleukin 15 protein complex

#1036
20190070262
2019-03-07

INTERLEUKIN-18 VARIANTS AND METHODS OF USE

#1037
20190070261
2019-03-07

MATERIALS AND METHODS FOR MODULATING GLUCOSE UPTAKE

#1038
20190070256
2019-03-07

Systems and methods for improved delivery of osteoinductive molecules in bone repair

#1039
20190070253
2019-03-07

Combination product for the prevention of sexually transmitted infections

#1040
20190070234
2019-03-07

METHOD FOR FOODBORNE PATHOGEN REDUCTION IN POULTRY

#1041
20190070206
2019-03-07

Radiation - Sterilized Biodegradable Drug Delivery Compositions

#1042
20190070205
2019-03-07

Compounds for use in wound healing and angiogenesis

#1043
20190070201
2019-03-07

FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA

#1044
20190070193
2019-03-07

Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation

#1045
20190070178
2019-03-07

METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS

#1046
20190070176
2019-03-07

Method of increasing bioavailability and/or prolonging ophthalmic action of a drug

#1047
20190070173
2019-03-07

Combinations for the treatment of neuroblastoma

#1048
20190070162
2019-03-07

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

#1049
20190070159
2019-03-07

NOVEL PHARMACEUTICAL USES

#1050
20190070156
2019-03-07

Treatment of debilitating fatigue

#1051
20190070150
2019-03-07

Method for treating hepatic encephalopathy

#1052
20190070144
2019-03-07

Treatment of circadian rhythm disorders

#1053
20190070142
2019-03-07

Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies

#1054
20190070133
2019-03-07

Pharmaceutical composition for improving or preventing progression of chronic kidney disease

#1055
20190070126
2019-03-07

Method for supporting memory function and/or cognitive function

#1056
20190070121
2019-03-07

Controlled release dosage form with enhanced pharmacokinetics

#1057
20190070118
2019-03-07

Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

#1058
20190070080
2019-03-07

Artificial saliva

#1059
20190062842
2019-02-28

Compositions and methods for treating cancers

#1060
20190062745
2019-02-28

MicroRNA composition for the treatment of neuroblastoma

#1061
20190062457
2019-02-28

Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer

#1062
20190062445
2019-02-28

FULLY HUMAN ANTIBODIES AGAINST HUMAN 4-1BB

#1063
20190062273
2019-02-28

HEPATOPROTECTANT ACETAMINOPHEN MUTUAL PRODRUGS

#1064
20190062262
2019-02-28

Compositions and Methods for the Treatment of Fatty Acid Metabolism Disorders

#1065
20190062254
2019-02-28

COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF

#1066
20190060477
2019-02-28

Polymeric conjugates and uses thereof

#1067
20190060464
2019-02-28

Silicone-based composition for skin treatment

#1068
20190060462
2019-02-28

Compound to treat Sjogren's syndrome

#1069
20190060411
2019-02-28

Insulin Glargine/Lixisenatide Fixed Ratio Formulation

#1070
20190060405
2019-02-28

Pharmaceutical composition comprising IL-34 and a mTOR inhibitor

#1071
20190060401
2019-02-28

TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN

#1072
20190060383
2019-02-28

Compositions and methods for controlling carbohydrate and fat metabolism

#1073
20190060362
2019-02-28

RAR selective agonists in combination with immune modulators for cancer immunotherapy

#1074
20190060357
2019-02-28

COMPOSITION AND METHOD FOR TREATING MIGRAINES

#1075
20190060343
2019-02-28

Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

#1076
20190060337
2019-02-28

COMPOSITIONS COMPRISING BETA-GLUCOGALLIN AND THERAPEUTIC APPLICATIONS THEREOF IN CONTROLLED KINETICS OF CARBOHYDRATE BREAKDOWN AND MONOSACCHARIDE ABSORPTION

#1077
20190060335
2019-02-28

Oral lipid supplements for treating pain and fibromyalgia

#1078
20190060332
2019-02-28

Concentrated therapeutic phospholipid compositions

#1079
20190060327
2019-02-28

Methods and compositions for treating psoriasis

#1080
20190060318
2019-02-28

Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates

#1081
20190060317
2019-02-28

Compositions and methods for treating cancer

#1082
20190060308
2019-02-28

PHARMACEUTICAL COMPOSITION COMPRISING AN OMEGA-3 FATTY ACID AND A HYDROXY-DERIVATIVE OF A STATIN AND METHODS OF USING SAME

#1083
20190060306
2019-02-28

ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR

#1084
20190060305
2019-02-28

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

#1085
20190060300
2019-02-28

Self-Emulsifying Compositions of CB2 Receptor Modulators

#1086
20190060298
2019-02-28

NEW DRUG FOR THE TREATMENT AND/OR PREVENTION OF DEPRESSIVE DISORDERS

#1087
20190060291
2019-02-28

AZETIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#1088
20190060286
2019-02-28

Chemotherapeutic Methods

#1089
20190060275
2019-02-28

Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer

#1090
20190060271
2019-02-28

Crosslinker enhanced repair of connective tissues

#1091
20190060263
2019-02-28

Compositions containing benzoate compound and tannic acid for treating central nervous system disorders

#1092
20190060262
2019-02-28

Enhanced expression of RNA vectors

#1093
20190060253
2019-02-28

Formulation of Curcumin with Enhanced Bioavailability of Curcumin and method of preparation and treatment thereof

#1094
20190060227
2019-02-28

Cannabinoid compositions comprising cannabis oil and methods of making thereof

#1095
20190060201
2019-02-28

Topical sanitizing formulations and uses thereof

#1096
20190056386
2019-02-21

ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION

#1097
20190055557
2019-02-21

Compositions and Methods For Treating Cachexia

#1098
20190055234
2019-02-21

Compositions and methods for inhibiting kinases

#1099
20190054146
2019-02-21

PREVENTION OF HYPOGLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS

#1100
20190054113
2019-02-21

METHODS FOR TREATING MUSCULAR DYSTROPHY

#1101
20190054107
2019-02-21

Compositions and methods for treating an infection

#1102
20190054104
2019-02-21

Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria

#1103
20190054085
2019-02-21

COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

#1104
20190054083
2019-02-21

METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE

#1105
20190054079
2019-02-21

ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR

#1106
20190054071
2019-02-21

Small molecule inhibitors of pendrin ion exchange and pharmaceutical compositions

#1107
20190054061
2019-02-21

Compositions and methods for treating an infection

#1108
20190054060
2019-02-21

COMPOSITIONS AND METHODS FOR TREATMENT OF INFLUENZA VIRUS

#1109
20190054051
2019-02-21

DOPA Formulations for Treatments of Parkinson's Disease

#1110
20190054038
2019-02-21

NITRIC OXIDE GENERATING FORMULATIONS AND KITS

#1111
20190053988
2019-02-21

METHOD FOR PRODUCING CELLULOSE FIBERS SUITABLE FOR USE IN A THICKENING COMPOSITION, METHOD FOR PRODUCING A THICKENING COMPOSITION, AND METHOD FOR THICKENING A COMPOSITION

#1112
20190048096
2019-02-14

Anti-CTLA-4 antibodies and uses thereof

#1113
20190048091
2019-02-14

Treatment for multiple myeloma (MM)

#1114
20190048072
2019-02-14

USE OF IL-1beta BINDING ANTIBODIES

#1115
20190048055
2019-02-14

ALT-803 IN COMBINATION WITH ANTI-CD38 ANTIBODY FOR CANCER THERAPIES

#1116
20190048040
2019-02-14

Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase

#1117
20190047985
2019-02-14

Artificial catalyst system for selective acylation of chromosome protein

#1118
20190047970
2019-02-14

Carboxylic diarylthiazepineamines as mu-opioid receptor agonists

#1119
20190047932
2019-02-14

Nuclear receptor modulators and their use for the treatment and prevention of cancer

#1120
20190046655
2019-02-14

Cadherin-17 specific antibodies and cytotoxic cells for cancer treatment

#1121
20190046646
2019-02-14

Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists

#1122
20190046644
2019-02-14

IMPAIRED ENERGY PROCESSING DISORDERS AND MITOCHONDRIAL DEFICIENCY

#1123
20190046595
2019-02-14

METHODS OF USING SMECTITE COMPOSITIONS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES AND SYMPTOMS

#1124
20190046593
2019-02-14

Compositions for treating candidiasis infections

#1125
20190046564
2019-02-14

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY ARTHRITIS

#1126
20190046563
2019-02-14

NANOBUBBLE-CONTAINING COMPOSITION AND USE THEREOF

#1127
20190046559
2019-02-14

Gel formulation for the prevention and treatment of gastrointestinal distress in horses and other species

#1128
20190046558
2019-02-14

COMPOSITION AND METHODS OF INHIBITING AMYLASE-MEDIATED HYDROLYSIS OF ALPHA (1 to 4)-LINKED GLUCOSE POLYMERS

#1129
20190046556
2019-02-14

Methods and Pharmaceutical Compositions for the Prophylactic Treatment of Peritoneal Carcinomatosis

#1130
20190046552
2019-02-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HCV INFECTION

#1131
20190046542
2019-02-14

Natural combination hormone replacement formulations and therapies

#1132
20190046533
2019-02-14

Combination therapy for the treatment of cancer

#1133
20190046531
2019-02-14

Methods and compositions for treating abnormal cell growth

#1134
20190046517
2019-02-14

Methods and compositions for treatment of mitochondrial toxicity

#1135
20190046504
2019-02-14

MATERIALS AND METHODS FOR IMPROVING GASTROINTESTINAL FUNCTION

#1136
20190046501
2019-02-14

Taxane analogs for the treatment of brain cancer

#1137
20190046495
2019-02-14

Reducing the risk of pathological effects of traumatic brain injury

#1138
20190046492
2019-02-14

TREATMENT AND PREVENTION OF BONE LOSS USING RESOLVINS

#1139
20190046484
2019-02-14

METHODS FOR TREATING NEUROBLASTOMA

#1140
20190046481
2019-02-14

TRANSDERMAL FORMULATIONS FOR DELIVERY OF PROPIONIC AND ACETIC ACID NSAIDS, AND THEIR USE IN THE TREATMENT OF NSAID-RESPONSIVE DISEASES AND CONDITIONS

#1141
20190046477
2019-02-14

Composition for treating diabetes, containing extract of yukmijihwangtang

#1142
20190046472
2019-02-14

Igmesine for use in the treatment of neurodegenerative diseases

#1143
20190046467
2019-02-14

COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM-FORMING BACTERIA

#1144
20190046433
2019-02-14

Combination therapy for COPD

#1145
20190045789
2019-02-14

ANTIMICROBIAL COMPOSITION

#1146
20190040448
2019-02-07

METHODS OF DIAGNOSING AND TREATING B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

#1147
20190040357
2019-02-07

Method for separating cells using immunorosettes and magnetic particles

#1148
20190040026
2019-02-07

Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof

#1149
20190040017
2019-02-07

AMINOBENZIMIDAZOLE DERIVATIVES

#1150
20190038813
2019-02-07

ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN

#1151
20190038781
2019-02-07

Assessment of coronary heart disease with carbon dioxide

#1152
20190038767
2019-02-07

ST-246 liquid formulations and methods

#1153
20190038725
2019-02-07

Cancer treatment

#1154
20190038719
2019-02-07

Combination preparation including a corticosteroid and exosomes

#1155
20190038697
2019-02-07

Compositions comprising kakadu plum extract or acai berry extract

#1156
20190038696
2019-02-07

Herbal compositions and methods for the prevention and treatment of plant of nail infections

#1157
20190038692
2019-02-07

Cosmetic compositions

#1158
20190038687
2019-02-07

Nutritional composition

#1159
20190038675
2019-02-07

Anti-angiogenic therapy based on exosomes derived from menstrual stem cells

#1160
20190038661
2019-02-07

Rapid release pharmaceutical formulations containing algal cellulose

#1161
20190038656
2019-02-07

Anthranilyl-adenosinemonosulfamate analogs and uses thereof

#1162
20190038655
2019-02-07

Chemicals and methods to prevent and treat TGF-beta mediated activation of fibroblasts to reduce and treat cancer and fibrosis

#1163
20190038650
2019-02-07

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS AND HEPATOSTEATOSIS AND OTHER DISEASES

#1164
20190038641
2019-02-07

COMBINATION THERAPY FOR CASTRATION-RESISTANT PROSTRATE CANCER

#1165
20190038640
2019-02-07

COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND NATURAL COMPOUNDS FOR THE PROMOTION OF HEALTHY BRAIN AGING

#1166
20190038619
2019-02-07

Product and method for treating diarrhea

#1167
20190038616
2019-02-07

Anti-neutrophil activity on innate immune response

#1168
20190038615
2019-02-07

PHARMACEUTICAL COMPOSITIONS AND ADMINISTRATIONS THEREOF

#1169
20190038613
2019-02-07

COMBINATION THERAPY

#1170
20190038610
2019-02-07

Cancer therapy

#1171
20190038600
2019-02-07

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES

#1172
20190038599
2019-02-07

TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER

#1173
20190038598
2019-02-07

PHARMACEUTICAL COMPOSITION INCLUDING DORZOLAMIDE AND BRIMONIDINE

#1174
20190038588
2019-02-07

NOVEL CLASS OF COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE

#1175
20190038583
2019-02-07

Methods and compositions for increasing the anaerobic working capacity in tissues

#1176
20190038580
2019-02-07

Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis

#1177
20190038577
2019-02-07

Snacking product with capsaicin or analogue thereof

#1178
20190038573
2019-02-07

ION CHANNEL ACTIVATORS AND METHODS OF USE

#1179
20190038570
2019-02-07

SUBLINGUAL AND BUCCAL FILM COMPOSITIONS

#1180
20190038548
2019-02-07

Compositions for respiratory delivery of active agents and associated methods and systems

#1181
20190037889
2019-02-07

Supplement for the prevention and treatment of gastrointestinal distress in horses and other species

#1182
20190031774
2019-01-31

METHODS FOR TREATING HYPERLIPIDEMIA IN DIABETIC PATIENTS BY ADMINISTERING A PCSK9 INHIBITOR

#1183
20190031762
2019-01-31

POSTERIOR OCULAR FIBROSIS INHIBITION BY ANTAGONIZING PLACENTAL GROWTH FACTOR

#1184
20190031734
2019-01-31

Compositions and methods for inhibiting Wnt signaling

#1185
20190031732
2019-01-31

Compositions and methods for treating cancers

#1186
20190031677
2019-01-31

Ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them

#1187
20190031659
2019-01-31

Processes for producing diazabicyclooctane compounds

#1188
20190031653
2019-01-31

Derivatives and methods of treating hepatitis B infections

#1189
20190031651
2019-01-31

GLS1 inhibitors for treating disease

#1190
20190030164
2019-01-31

Trace elements

#1191
20190030146
2019-01-31

Bacterial ghosts for the treatment of cancer

#1192
20190030113
2019-01-31

DIPEPTIDYL ALDEHYDES FOR THE TREATMENT AND/OR PREVENTION OF PARASITIC DISEASES

#1193
20190030108
2019-01-31

Water extracts of cinnamon and radix astragali

#1194
20190030102
2019-01-31

HYDROGENATION OF CANNABIS OIL

#1195
20190030101
2019-01-31

Printable cannabinoid and terpene compositions

#1196
20190030077
2019-01-31

ENHANCEMENT OF STEM CELL ENGRAFTMENT WITH ONCOSTATIN M

#1197
20190030074
2019-01-31

Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative Compound

#1198
20190030066
2019-01-31

ANTITHROMBIN-HEPARIN COMPOSITIONS AND METHODS

#1199
20190030062
2019-01-31

Cannabinoid composition and method for treating pain

#1200
20190030055
2019-01-31

TOPICAL ANTIFUNGAL PASTES AND METHODS OF USE THEREOF